These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15476915)

  • 1. The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.
    Ozminkowski RJ; Marder WD; Hawkins K; Wang S; Stallings SC; Finkelstein SN; Sinskey AJ; Wierz D
    Clin Ther; 2004 Aug; 26(8):1341-54. PubMed ID: 15476915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs.
    Reynolds MW; Stephen R; Seaman C; Rajagopalan K
    J Med Econ; 2010 Mar; 13(1):90-8. PubMed ID: 20078189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.
    Birnbaum HG; Ivanova JI; Samuels S; Davis M; Cremieux PY; Phillips AL; Meletiche D
    Curr Med Res Opin; 2009 Apr; 25(4):869-77. PubMed ID: 19232041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
    Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relevance of multiple sclerosis drugs in private health insurance (PHI)].
    Wild F
    Versicherungsmedizin; 2015 Jun; 67(2):78-81. PubMed ID: 26281288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease modifying therapies continue to drive up health care cost among individuals with multiple sclerosis.
    Kim Y; Krause TM; Blum P; Freeman L
    Mult Scler Relat Disord; 2019 May; 30():69-75. PubMed ID: 30738875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis.
    Yermakov S; Davis M; Calnan M; Fay M; Cox-Buckley B; Sarda S; Duh MS; Iyer R
    J Med Econ; 2015; 18(9):711-20. PubMed ID: 25903661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.
    Ha-Vinh P; Nauleau S; Clementz M; Régnard P; Sauze L; Clavaud H
    Presse Med; 2019 Jan; 48(1 Pt 1):e1-e19. PubMed ID: 30528148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.
    Landfeldt E; Castelo-Branco A; Svedbom A; Löfroth E; Kavaliunas A; Hillert J
    J Neurol; 2018 Mar; 265(3):701-707. PubMed ID: 29392457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records.
    Corvino FA; Oliveri D; Phillips AL
    Curr Med Res Opin; 2017 Jun; 33(6):1127-1132. PubMed ID: 28318337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis.
    Sternberg Z; Leung C; Sternberg D; Yu J; Hojnacki D
    Cardiovasc Ther; 2014 Apr; 32(2):33-9. PubMed ID: 24119301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE; Cox ER
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults.
    Adrion ER; Ryan AM; Seltzer AC; Chen LM; Ayanian JZ; Nallamothu BK
    JAMA Intern Med; 2016 Sep; 176(9):1325-32. PubMed ID: 27367932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.
    Windt R; Glaeske G; Hoffmann F
    Int J Clin Pharm; 2013 Dec; 35(6):1229-35. PubMed ID: 24104761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employer-sponsored prescription drug benefits.
    Baker C; Kramer N
    Mon Labor Rev; 1991 Feb; 114(2):31-5. PubMed ID: 10110198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.